Table 2.
Category and grade recommendations for ECP according to the ASFA guidelines of 2019 [10]
| Indication | Category | Grade |
|---|---|---|
| Transplant setting | ||
| HSCT | ||
| aGvHD | II | 1C |
| cGvHD | II | 1B |
| Lung transplant | ||
| Bronchiolitis obliterans syndrome | II | 1C |
| Cardiac transplant | ||
| Rejection prophylaxis | II | 2A |
| Cellular rejection | II | 1B |
| Liver transplant | ||
| Densitization (ABOi) | III | 2C |
| Acute rejection/immune suppression withdrawal | III | 2B |
| Dermatology | ||
| Cutaneous T-cell lymphoma | ||
| Erythrodermic | I | 1B |
| Nonerythrodermic | III | 2C |
| Atopic dermatitis | III | 2A |
| Pemphigus vulgaris, severe | III | 2C |
| Psoriasis, disseminated pustular | III | 2B |
| Other | ||
| Skleroderma | III | 2A |
| Nephrogenic systemic fibrosis | III | 2C |
| Crohn's disease | III | 2C |